S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:CYRN

Cyren Stock Forecast, Price & News

$0.31
-0.04 (-11.33%)
(As of 12/3/2021 04:00 PM ET)
Add
Compare
Today's Range
$0.31
$0.37
50-Day Range
$0.31
$0.63
52-Week Range
$0.31
$1.75
Volume
2.18 million shs
Average Volume
1.58 million shs
Market Capitalization
$28.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.25
30 days | 90 days | 365 days | Advanced Chart
Receive CYRN News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyren and its competitors with MarketBeat's FREE daily newsletter.


Cyren logo

About Cyren

CYREN Ltd. engages in the provision of cloud-based security solutions. Its products include web and electronic mail security, cyber intelligence suite, malware attack detection, mobile security, uniform resource locator filtering, phishing intelligence feed, and anti-spam. The company was founded by Amir Lev, Gideon Mantel, and Nahum Sharfman on February 10, 1991 and is headquartered in Herzliya, Israel.

Headlines

Cyren (NASDAQ:CYRN) Releases Earnings Results, Hits Estimates
November 16, 2021 |  americanbankingnews.com
Cyren Announces Third Quarter 2021 Financial Results
November 15, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRN
Employees
222
Year Founded
N/A

Sales & Book Value

Annual Sales
$36.39 million
Book Value
$0.23 per share

Profitability

Net Income
$-17.26 million
Pretax Margin
-64.41%

Debt

Price-To-Earnings

Miscellaneous

Free Float
38,188,000
Market Cap
$28.28 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/15/2021
Today
12/04/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/28/2022

MarketRank

Overall MarketRank

1.41 out of 5 stars

Computer And Technology Sector

725th out of 892 stocks

Prepackaged Software Industry

216th out of 267 stocks

Analyst Opinion: 0.0Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.0 5 -4 -3 -2 -1 -












Cyren (NASDAQ:CYRN) Frequently Asked Questions

How has Cyren's stock price been impacted by COVID-19?

Cyren's stock was trading at $0.95 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CYRN shares have decreased by 67.1% and is now trading at $0.3130.
View which stocks have been most impacted by COVID-19
.

When is Cyren's next earnings date?

Cyren is scheduled to release its next quarterly earnings announcement on Monday, February 28th 2022.
View our earnings forecast for Cyren
.

How were Cyren's earnings last quarter?

Cyren Ltd. (NASDAQ:CYRN) posted its earnings results on Monday, November, 15th. The technology company reported ($0.06) EPS for the quarter, hitting the Zacks' consensus estimate of ($0.06). The technology company earned $7.46 million during the quarter. Cyren had a negative net margin of 63.77% and a negative trailing twelve-month return on equity of 104.30%.
View Cyren's earnings history
.

Who are Cyren's key executives?

Cyren's management team includes the following people:
  • Brett Michael Jackson, Chief Executive Officer & Director (LinkedIn Profile)
  • Boris Bogod, Vice President-Global Cloud Operations
  • Kenneth J. Tarpey, Chief Financial Officer
  • Lior Kohavi, Chief Strategy Officer & EVP-Advanced Solutions
  • Atif Ahmed, Vice President-EMEA Sales

What other stocks do shareholders of Cyren own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), OPKO Health (OPK), Vaxart (VXRT), Biocept (BIOC), iBio (IBIO), MEI Pharma (MEIP), VBI Vaccines (VBIV) and Ampio Pharmaceuticals (AMPE).

What is Cyren's stock symbol?

Cyren trades on the NASDAQ under the ticker symbol "CYRN."

Who are Cyren's major shareholders?

Cyren's stock is owned by a number of retail and institutional investors. Top institutional investors include Herald Investment Management Ltd (0.13%), Sassicaia Capital Advisers LLC (0.06%), Citadel Advisors LLC (0.06%) and Concourse Financial Group Securities Inc. (0.00%). Company insiders that own Cyren stock include Atif Ahmed, Brett Michael Jackson, Eva Lilias Markowitz and Sigurdur Arnar Stefnisson.
View institutional ownership trends for Cyren
.

Which major investors are selling Cyren stock?

CYRN stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC. Company insiders that have sold Cyren company stock in the last year include Brett Michael Jackson, and Eva Lilias Markowitz.
View insider buying and selling activity for Cyren
or view top insider-selling stocks.

Which major investors are buying Cyren stock?

CYRN stock was purchased by a variety of institutional investors in the last quarter, including Sassicaia Capital Advisers LLC, and Herald Investment Management Ltd.
View insider buying and selling activity for Cyren
or or view top insider-buying stocks.

How do I buy shares of Cyren?

Shares of CYRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cyren's stock price today?

One share of CYRN stock can currently be purchased for approximately $0.31.

How much money does Cyren make?

Cyren has a market capitalization of $28.28 million and generates $36.39 million in revenue each year. The technology company earns $-17.26 million in net income (profit) each year or ($0.28) on an earnings per share basis.

How many employees does Cyren have?

Cyren employs 222 workers across the globe.

What is Cyren's official website?

The official website for Cyren is www.cyren.com.

Where are Cyren's headquarters?

How can I contact Cyren?

Cyren's mailing address is 10 Ha-Menofim St. 5th Floor, Herzliya L3, 4672561. The technology company can be reached via phone at (729) 863-6888, via email at [email protected], or via fax at 972-9894-8214.


This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.